JP2013508348A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013508348A5 JP2013508348A5 JP2012534793A JP2012534793A JP2013508348A5 JP 2013508348 A5 JP2013508348 A5 JP 2013508348A5 JP 2012534793 A JP2012534793 A JP 2012534793A JP 2012534793 A JP2012534793 A JP 2012534793A JP 2013508348 A5 JP2013508348 A5 JP 2013508348A5
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- oil mixture
- dha
- epa
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25429309P | 2009-10-23 | 2009-10-23 | |
| US25429609P | 2009-10-23 | 2009-10-23 | |
| US25429109P | 2009-10-23 | 2009-10-23 | |
| US61/254,293 | 2009-10-23 | ||
| US61/254,291 | 2009-10-23 | ||
| US61/254,296 | 2009-10-23 | ||
| PCT/IB2010/002854 WO2011048493A1 (en) | 2009-10-23 | 2010-10-22 | Coated capsules and tablets of a fatty acid oil mixture |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015147073A Division JP6151317B2 (ja) | 2009-10-23 | 2015-07-24 | 脂肪酸油混合物の被覆型カプセル剤および錠剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013508348A JP2013508348A (ja) | 2013-03-07 |
| JP2013508348A5 true JP2013508348A5 (enExample) | 2017-02-02 |
| JP6116905B2 JP6116905B2 (ja) | 2017-04-19 |
Family
ID=43899870
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012534793A Active JP6116905B2 (ja) | 2009-10-23 | 2010-10-22 | 脂肪酸油混合物の被覆型カプセル剤および錠剤 |
| JP2015147073A Active JP6151317B2 (ja) | 2009-10-23 | 2015-07-24 | 脂肪酸油混合物の被覆型カプセル剤および錠剤 |
| JP2017102240A Active JP6835664B2 (ja) | 2009-10-23 | 2017-05-24 | 脂肪酸油混合物の被覆型カプセル剤および錠剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015147073A Active JP6151317B2 (ja) | 2009-10-23 | 2015-07-24 | 脂肪酸油混合物の被覆型カプセル剤および錠剤 |
| JP2017102240A Active JP6835664B2 (ja) | 2009-10-23 | 2017-05-24 | 脂肪酸油混合物の被覆型カプセル剤および錠剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9370493B2 (enExample) |
| EP (1) | EP2490678B1 (enExample) |
| JP (3) | JP6116905B2 (enExample) |
| KR (4) | KR20200013123A (enExample) |
| CN (1) | CN102724972A (enExample) |
| AU (1) | AU2010309517B2 (enExample) |
| CA (1) | CA2781525C (enExample) |
| ES (1) | ES2895477T3 (enExample) |
| WO (1) | WO2011048493A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010222648B2 (en) | 2009-03-09 | 2016-07-07 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof |
| JP5951489B2 (ja) | 2009-10-16 | 2016-07-13 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ | 組成物 |
| WO2011048493A1 (en) * | 2009-10-23 | 2011-04-28 | Pronova Biopharma Norge As | Coated capsules and tablets of a fatty acid oil mixture |
| EP2613766A4 (en) * | 2010-09-08 | 2014-04-09 | Pronova Biopharma Norge As | COMPOSITIONS COMPRISING AN OIL MIXTURE CONSISTING OF FATTY ACIDS COMPRISING EPA AND DHA AS FREE ACID, SURFACTANT AND STATIN |
| EP2613767A4 (en) * | 2010-09-08 | 2014-03-19 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin |
| AR082930A1 (es) * | 2010-09-08 | 2013-01-16 | Pronova Biopharma Norge As | Composiciones que comprenden una mezcla oleosa de acidos grasos, un tensioactivo y una estatina |
| US8697676B2 (en) | 2011-06-15 | 2014-04-15 | Ronald E Rosedale | Omega-3 fatty acid nutriceutical composition and optimization method |
| SG11201403805WA (en) | 2012-01-06 | 2014-08-28 | Omthera Pharmaceuticals Inc | Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form |
| US10898458B2 (en) | 2012-03-30 | 2021-01-26 | Micelle Biopharma, Inc. | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states |
| US20160228397A1 (en) | 2012-03-30 | 2016-08-11 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
| US9480651B2 (en) | 2012-03-30 | 2016-11-01 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms |
| AU2013240427B2 (en) | 2012-03-30 | 2017-08-03 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
| AR095182A1 (es) | 2012-05-07 | 2015-09-30 | Omthera Pharmaceuticals Inc | Composiciones de estatinas y ácidos grasos omega-3 |
| CN104968215B (zh) * | 2012-12-12 | 2018-09-11 | 罗纳德·罗斯代尔 | ω-3脂肪酸营养药组合物和优化方法 |
| KR101534494B1 (ko) * | 2014-01-09 | 2015-07-07 | 충남대학교산학협력단 | Ｄｈａ를 포함하는 혈관 질환 예방 및 치료용 약학적 조성물 |
| WO2016117057A1 (ja) * | 2015-01-21 | 2016-07-28 | 持田製薬株式会社 | ω３脂肪酸の自己乳化組成物 |
| MA41611A (fr) * | 2015-02-23 | 2018-01-02 | Omthera Pharmaceuticals Inc | Préparations en milli-capsules comprenant des acides gras polyinsaturés libres |
| WO2016179137A1 (en) * | 2015-05-04 | 2016-11-10 | Cytometix, Inc. | Compositions and methods for delivery of polyunsaturated fatty acid derivatives and analogs |
| AU2017232554B2 (en) * | 2016-03-16 | 2020-05-14 | Golden Omega Norway As | Powders and tablets comprising omega-3 fatty acid derivatives and methods for their production |
| AU2017301077B2 (en) * | 2016-08-12 | 2022-07-07 | Pharmako Biotechnologies Pty Limited | Omega-3 compositions and methods relating thereto |
| WO2019178444A1 (en) | 2018-03-15 | 2019-09-19 | R.P. Scherer Technologies, Llc | Enteric softgel capsules |
| TR201915787A2 (tr) * | 2019-10-14 | 2021-04-21 | Yilmaz Usta Duygu | Bosentan monohi̇drat yüklenmi̇ş sivi kendi̇li̇ği̇nden nanoemülsi̇fi̇ye i̇laç taşiyici si̇stem ve tablet formülasyonu |
| CN111067876B (zh) * | 2019-12-04 | 2022-08-16 | 宁夏大学 | 一种α-亚麻酸双层片及其制备方法 |
| WO2025234509A1 (ko) * | 2024-05-08 | 2025-11-13 | 코스맥스바이오 주식회사 | pH 의존성 필름 조성물 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| AU633959B2 (en) * | 1989-08-17 | 1993-02-11 | Cortecs Limited | Pharmaceutical formulations |
| JPH06181725A (ja) * | 1992-12-17 | 1994-07-05 | Kiteii:Kk | 易酸化性油状物の固形化剤 |
| JP2004135681A (ja) * | 1993-11-10 | 2004-05-13 | Yakken:Kk | 食品組成物 |
| JPH07255436A (ja) * | 1994-03-25 | 1995-10-09 | Kiteii:Kk | 複合飲料 |
| MY118354A (en) | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
| GB9509764D0 (en) | 1995-05-15 | 1995-07-05 | Tillotts Pharma Ag | Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids |
| KR100569319B1 (ko) * | 1997-10-30 | 2006-04-07 | 모리시타 진탄 가부시키가이샤 | 불포화 지방산 또는 이들의 유도체를 내용물로 하는 캡슐제제 및 그의 제조방법 |
| ATE497384T1 (de) * | 1997-12-10 | 2011-02-15 | Cyclosporine Therapeutics Ltd | Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen |
| AU3843999A (en) * | 1998-05-07 | 1999-11-23 | Elan Corporation, Plc | Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems |
| US20050037065A1 (en) | 1999-05-27 | 2005-02-17 | Drugtech Corporation | Nutritional formulations |
| ES2246769T3 (es) * | 2000-05-22 | 2006-03-01 | Pro Aparts - Investimentos E Consultoria Lda | Composicion de acidos grasos que contiene al menos 80% en peso de epa y dha o sus derivados y su uso farmaceutico. |
| GB0210212D0 (en) * | 2002-05-03 | 2002-06-12 | Univ Southampton | Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability |
| EP1501493B1 (en) * | 2002-05-03 | 2009-10-07 | Pronova BioPharma Norge AS | Use of epa and dha in secondary prevention of strokes |
| SE0202188D0 (sv) | 2002-07-11 | 2002-07-11 | Pronova Biocare As | A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| US20040254357A1 (en) | 2002-12-19 | 2004-12-16 | Zaloga Gary P. | Fatty acid phenolic conjugates |
| SE0303513D0 (sv) * | 2003-12-19 | 2003-12-19 | Pronova Biocare As | Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| GB0403247D0 (en) * | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
| GB0413730D0 (en) * | 2004-06-18 | 2004-07-21 | Tillotts Pharma Ag | A pharmaceutical composition and its use |
| GB0413729D0 (en) * | 2004-06-18 | 2004-07-21 | Tillotts Pharma Ag | A pharmaceutical composition and its use |
| AU2005256322C1 (en) | 2004-06-28 | 2011-07-07 | Veloxis Pharmaceuticals, Inc. | Porous tablets as carriers for liquid formulations |
| US20060051462A1 (en) * | 2004-09-03 | 2006-03-09 | Wang Jimmy X | Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients |
| EP1790339B1 (en) * | 2005-07-08 | 2014-06-04 | Mochida Pharmaceutical Co., Ltd. | Composition for prevention of occurrence of cardiovascular event |
| CA2634139C (en) | 2005-12-20 | 2015-06-23 | Cenestra, Llc. | Omega 3 fatty acid formulations |
| JP2009525992A (ja) * | 2006-02-10 | 2009-07-16 | スポーツコム デンマーク アプス | コーティングを施した錠剤、その製造方法、及び関連する使用 |
| MY153288A (en) * | 2006-06-28 | 2015-01-29 | Hovid Berhad | An effective pharmaceutical carrier for poorly bioavailable drugs |
| CA2677670C (en) * | 2007-03-20 | 2010-08-03 | Centre De Recherche Sur Les Biotechnologies Marines | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof |
| CA2692394A1 (en) * | 2007-07-06 | 2009-01-15 | Seth J. Baum | Fatty acid compositions and methods of use |
| UA102477C2 (en) * | 2008-01-10 | 2013-07-10 | Такеда Фармасьютикал Компани Лимитед | Capsule composition |
| US20100062057A1 (en) * | 2008-09-10 | 2010-03-11 | Pronova BioPharma Norge AS. | Formulation |
| US20100130608A1 (en) * | 2008-10-01 | 2010-05-27 | Martek Biosciences Corporation | Compositions and methods for reducing triglyceride levels |
| AU2010222648B2 (en) * | 2009-03-09 | 2016-07-07 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof |
| CA3059911C (en) * | 2009-05-22 | 2022-01-11 | Mochida Pharmaceutical Co., Ltd. | Self-emulsifying composition of .omega.3 fatty acid |
| JP5951489B2 (ja) * | 2009-10-16 | 2016-07-13 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ | 組成物 |
| WO2011048493A1 (en) * | 2009-10-23 | 2011-04-28 | Pronova Biopharma Norge As | Coated capsules and tablets of a fatty acid oil mixture |
-
2010
- 2010-10-22 WO PCT/IB2010/002854 patent/WO2011048493A1/en not_active Ceased
- 2010-10-22 JP JP2012534793A patent/JP6116905B2/ja active Active
- 2010-10-22 CN CN2010800586253A patent/CN102724972A/zh active Pending
- 2010-10-22 KR KR1020207002980A patent/KR20200013123A/ko not_active Ceased
- 2010-10-22 KR KR1020187027918A patent/KR102073938B1/ko active Active
- 2010-10-22 ES ES10824536T patent/ES2895477T3/es active Active
- 2010-10-22 US US13/503,465 patent/US9370493B2/en active Active
- 2010-10-22 KR KR1020217020158A patent/KR102354949B1/ko active Active
- 2010-10-22 EP EP10824536.6A patent/EP2490678B1/en active Active
- 2010-10-22 KR KR1020127013219A patent/KR101904388B1/ko active Active
- 2010-10-22 AU AU2010309517A patent/AU2010309517B2/en active Active
- 2010-10-22 CA CA2781525A patent/CA2781525C/en active Active
-
2015
- 2015-07-24 JP JP2015147073A patent/JP6151317B2/ja active Active
-
2017
- 2017-05-24 JP JP2017102240A patent/JP6835664B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6151317B2 (ja) | 脂肪酸油混合物の被覆型カプセル剤および錠剤 | |
| US11523999B2 (en) | Compositions comprising a fatty aged oil mixture and a free fatty acid, and methods and uses thereof | |
| JP2013508348A5 (enExample) | ||
| JP2013537186A (ja) | 脂肪酸油混合物と遊離脂肪酸とスタチンとを含む組成物 | |
| JP2013537185A (ja) | 遊離酸の形のｅｐａおよびｄｈａを含む脂肪酸油混合物と界面活性剤とスタチンとを含む組成物 | |
| WO2013072767A1 (en) | Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture | |
| TW201311294A (zh) | 含脂肪酸油混合物、界面活性劑與司它汀（ｓｔａｔｉｎ）的組成物 |